| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director | Chief Financial Officer
2 companies
Robert J Michel is Chief Financial Officer at DXR and has filed Form 4s across 2 companies. Robert J Michel's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $344K at current prices.
Historically, Robert J Michel's trades have earned a middling insider score of 62/100 across 11 rated trades. Over a 12-month horizon, 55.6% of those trades were profitable, with an average 12-month return of +6.1%.
The biggest single holding is DXR (~$288K) as Chief Financial Officer. Net of sales, the DXR filings show accumulation of 17,050 shares.
Robert J Michel has 72 Form 4 filings on record from April 2017 to June 2026, across 2 companies: Chief Financial Officer at Daxor (DXR), 2018–2026; Director at Bio Key International (BKYI), 2017–2025.
The 80 reported transactions were 59 stock awards, 14 open-market purchases and 7 option or other derivative awards.
Counted by filing, the open-market trades come to 12 purchases worth about $90K and no sales.
The largest open-market purchase was 2,500 shares of DXR at an average $7.42 on November 7, 2018, about $19K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | DXR Daxor Corporation | Chief Financial Officer | Buy | 1,000 | $9.90 | $9,900.00 | +5.0% | +4.6% | - | |
| Dec 9, 2025 | DXR Daxor Corp | Chief Financial Officer | Buy | 3,000 | $0.00 | - | +17.6% | -9.6% | - | |
| Mar 10, 2025 | DXR Daxor Corp | Chief Financial Officer | Buy | 1,000 | $8.00 | $8,000.00 | +6.2% | +19.4% | +48.2% | |
| Mar 27, 2024 | DXR Daxor Corp | Chief Financial Officer | Buy | 750 | $8.70 | $6,525.00 | +7.1% | +11.9% | -5.5% | |
| Dec 6, 2023 | DXR Daxor Corp | Chief Financial Officer | Buy | 120 | $7.75 | $930.00 | +1.2% | -3.1% | +13.7% | |
| Dec 1, 2023 | DXR Daxor Corp | Chief Financial Officer | Buy | 180 | $7.75 | $1,395.00 | +1.8% | +0.5% | +22.4% | |
| Nov 24, 2023 | DXR Daxor Corp | Chief Financial Officer | Buy | 500 | $7.94 | $3,970.00 | +5.1% | +3.9% | +16.9% | |
| Oct 13, 2023 | DXR Daxor Corp | Chief Financial Officer | Buy | 500 | $9.02 | $4,510.00 | +6.9% | +7.9% | -2.8% | |
| Mar 27, 2023 | DXR Daxor Corp | Chief Financial Officer | Buy | 4,750 | $0.00 | - | +46.1% | -13.7% | -23.2% | |
| Nov 18, 2022 | DXR Daxor Corp | Chief Financial Officer | Buy | 1,000 | $10.00 | $10,000.00 | +16.0% | -12.5% | -24.0% |